688 articles in this topic
Study reveals altered FTO enzyme activity and RNA modifications in clear cell renal carcinoma, suggesting new diagnostic markers.
New computational advances help identify which tumor peptides trigger immune responses, potentially revolutionizing personalized cancer therapy.
New research reveals how progenitor cells drive the transition from benign to malignant cancer, offering potential intervention targets.
Quantum computing breakthrough accelerates development of photodynamic therapy drugs for cancer treatment in major healthcare competition.
Breakthrough antibodies completely prevent EBV infection in lab models, offering hope against virus linked to cancer and chronic disease.
Comprehensive review reveals multiple resistance mechanisms and promising therapeutic approaches to improve outcomes for brain cancer patients.
Mismatch repair-deficient cancers accumulate mutations but respond remarkably well to immune checkpoint inhibitors across tumor types.
New review explores emerging synthetic lethal targets like ATR and WEE1 that could expand precision cancer therapy beyond current PARP inhibitor success.
Groundbreaking study shows PD-1 blockade achieves complete tumor elimination in most mismatch repair-deficient cancers, avoiding surgery.
New study identifies 7-gene signature linking air pollutants to hepatocellular carcinoma prognosis via immune dysfunction.
New research reveals young and elderly cervical cancer patients have completely different molecular signatures requiring age-specific treatments.
STAR-FACS technique enables researchers to isolate and study rare cancer cells with specific mutations, revealing how genetic changes drive tumor behavior.
